HomeAKUMS • NSE
add
Akums Drugs and Pharmaceuticals Ltd
Previous close
₹487.60
Day range
₹469.00 - ₹494.90
Year range
₹405.00 - ₹1,175.90
Market cap
72.25B INR
Avg Volume
264.80K
P/E ratio
21.05
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 10.24B | 0.48% |
Operating expense | 3.50B | 5.12% |
Net income | 634.75M | 5.49% |
Net profit margin | 6.20 | 5.08% |
Earnings per share | — | — |
EBITDA | 1.27B | 6.74% |
Effective tax rate | 32.37% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.76B | 108.07% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 30.64B | — |
Shares outstanding | 152.95M | — |
Price to book | 2.45 | — |
Return on assets | — | — |
Return on capital | 7.30% | — |
Cash Flow
Net change in cash
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 634.75M | 5.49% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Akums Drugs and Pharmaceuticals Limited is an Indian pharmaceutical Contract Development and Manufacturing Organization that serves both domestic and multinational pharmaceutical companies. The company was established in 2004 and became publicly listed on 6 August 2024. Wikipedia
Founded
2004
Website
Employees
7,536
